LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today announced receipt of regulatory approvals and the start of a targeted commercial ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the start of a limited commercial release for the Essenz™ Perfusion ...
An experimental device that isolates blood flow to the brain has the potential to revolutionize brain research. The device redirects the brain's blood supply through a pump that maintains or adjusts a ...
Fighting Inflammation in the Operating RoomHeart surgery with cardiopulmonary bypass (CPB), though life-saving, sparks a ...
“The Essenz Perfusion System has tremendous potential to become a key addition to our clinical practice, fusing a new era of technology with the skill and expertise of the perfusionist,” said Larry ...
Montana State University students published a paper alongside Duke University researchers in the Journal of Pediatric Pharmacology and Therapeutics this spring, validating a study on the optimal ...
It is critical to identify at-risk patients and minimize the deleterious effects of cardiopulmonary bypass (CPB) procedures in pediatric populations. The present study screened the plasma proteome of ...
Intuitive monitor featuring patient-tailored approach is now in clinical use in select centers in U.S. and Europe The Essenz Patient Monitor is the result of extensive consultation with perfusionists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results